Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor

By Duan Jianmin   Yong Chan-Loi   Garneau Michel   Amad Ma’an   Bolger Gordon   De Marte Josie   Montpetit Hélène   Otis Francois   Jutras Martin   Rhéaume Manon   White Peter W.   Llinàs-Brunet Montse   Bethell Richard C.   Cordingley Michael G.  

Xenobiotica, Vol. 42, Iss. 2, 2012-02 ,pp. : 164-172

Informa Healthcare

Access to resources Recommend Favorite

The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease

By Monteagudo E.   Fonsi M.   Chu X.   Bleasby K.   Evers R.   Pucci V.   Orsale M.V.   Cianetti S.   Ferrara M.   Harper S.   Laufer R.   Rowley M.   Summa V.  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 826-839

Informa Healthcare

Access to resources Recommend Favorite

A Combined Quantum/Classical Molecular Dynamics Study of the Catalytic Mechanism of HIV Protease

By Liu H.   Muller-Plathe F.   van Gunsteren W.F.  

Journal of Molecular Biology, Vol. 261, Iss. 3, 1996-08 ,pp. : 454-469

Academic Press

Access to resources Recommend Favorite

Inhibition of HCV NS3 protease by RNA aptamers in cells

By Funaji K.  

Nucleic Acids Research, Vol. 31, Iss. 7, 2003-04 ,pp. : 1935-1943

Oxford University Press

Access to resources Recommend Favorite

An Uniquely Purified HCV NS3 Protease and NS4A_21–34 Peptide Form a Highly Active Serine Protease Complex in Peptide Hydrolysis

By Sardana V.V.   Blue J.T.   Zugay-Murphy J.   Sardana M.K.   Kuo L.C.  

Protein Expression and Purification, Vol. 16, Iss. 3, 1999-08 ,pp. : 440-447

Academic Press

Access to resources Recommend Favorite